Add generic drug shortages to the long list of practice challenges that have emerged during the COVID-19 pandemic, according to several industry experts.
From the beginning, the pandemic threatened to trigger a huge disruption in the generic drug industry’s worldwide operations. “There were very big concerns about how our industry would be impacted, particularly when certain countries were closed off to the rest of the world,” said Erik Komendant, the vice